246 related articles for article (PubMed ID: 21537470)
21. CARMA3 Is Critical for the Initiation of Allergic Airway Inflammation.
Causton B; Ramadas RA; Cho JL; Jones K; Pardo-Saganta A; Rajagopal J; Xavier RJ; Medoff BD
J Immunol; 2015 Jul; 195(2):683-94. PubMed ID: 26041536
[TBL] [Abstract][Full Text] [Related]
22. CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and Metastasis.
Chang YW; Chiu CF; Lee KY; Hong CC; Wang YY; Cheng CC; Jan YH; Huang MS; Hsiao M; Ma JT; Su JL
Am J Respir Crit Care Med; 2015 Jul; 192(1):64-75. PubMed ID: 25906011
[TBL] [Abstract][Full Text] [Related]
23. CARMA3 Promotes Colorectal Cancer Cell Motility and Cancer Stemness via YAP-Mediated NF-κB Activation.
Chang TY; Wu CT; Sheu ML; Yang RS; Liu SH
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885061
[TBL] [Abstract][Full Text] [Related]
24. CARMA3 mediates lysophosphatidic acid-stimulated cytokine secretion by bronchial epithelial cells.
Medoff BD; Landry AL; Wittbold KA; Sandall BP; Derby MC; Cao Z; Adams JC; Xavier RJ
Am J Respir Cell Mol Biol; 2009 Mar; 40(3):286-94. PubMed ID: 18757306
[TBL] [Abstract][Full Text] [Related]
25. The Dishevelled, EGL-10 and pleckstrin (DEP) domain-containing protein DEPDC7 binds to CARMA2 and CARMA3 proteins, and regulates NF-κB activation.
D'Andrea EL; Ferravante A; Scudiero I; Zotti T; Reale C; Pizzulo M; De La Motte LR; De Maio C; Mazzone P; Telesio G; Vito P; Stilo R
PLoS One; 2014; 9(12):e116062. PubMed ID: 25541973
[TBL] [Abstract][Full Text] [Related]
26. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
[TBL] [Abstract][Full Text] [Related]
27. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
Stilo R; Varricchio E; Liguoro D; Leonardi A; Vito P
J Cell Sci; 2008 Apr; 121(Pt 8):1165-71. PubMed ID: 18349075
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
29. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
[TBL] [Abstract][Full Text] [Related]
30. CARMA3 is upregulated in human pancreatic carcinoma, and its depletion inhibits tumor proliferation, migration, and invasion.
Du S; Jia L; Zhang Y; Fang L; Zhang X; Fan Y
Tumour Biol; 2014 Jun; 35(6):5965-70. PubMed ID: 24633921
[TBL] [Abstract][Full Text] [Related]
31. A
De Bruyne M; Hoste L; Bogaert DJ; Van den Bossche L; Tavernier SJ; Parthoens E; Migaud M; Konopnicki D; Yombi JC; Lambrecht BN; van Daele S; Alves de Medeiros AK; Brochez L; Beyaert R; De Baere E; Puel A; Casanova JL; Goffard JC; Savvides SN; Haerynck F; Staal J; Dullaers M
Front Immunol; 2018; 9():2366. PubMed ID: 30429846
[No Abstract] [Full Text] [Related]
32. Neuroepithelial transforming gene 1 (Net1) binds to caspase activation and recruitment domain (CARD)- and membrane-associated guanylate kinase-like domain-containing (CARMA) proteins and regulates nuclear factor κB activation.
Vessichelli M; Ferravante A; Zotti T; Reale C; Scudiero I; Picariello G; Vito P; Stilo R
J Biol Chem; 2012 Apr; 287(17):13722-30. PubMed ID: 22343628
[TBL] [Abstract][Full Text] [Related]
33. CARMA3/NF-κB signaling contributes to tumorigenesis of hepatocellular carcinoma and is inhibited by sodium aescinate.
Hou H; Li WX; Cui X; Zhou DC; Zhang B; Geng XP
World J Gastroenterol; 2019 Sep; 25(36):5483-5493. PubMed ID: 31576094
[TBL] [Abstract][Full Text] [Related]
34. CARMA3 Is a Host Factor Regulating the Balance of Inflammatory and Antiviral Responses against Viral Infection.
Jiang C; Zhou Z; Quan Y; Zhang S; Wang T; Zhao X; Morrison C; Heise MT; He W; Miller MS; Lin X
Cell Rep; 2016 Mar; 14(10):2389-401. PubMed ID: 26947079
[TBL] [Abstract][Full Text] [Related]
35. Carma3 Protects from Liver Injury by Preserving Mitochondrial Integrity in Liver Sinusoidal Endothelial Cells.
Cheng L; Wei Z; Yang Z; Lu R; Yang M; Yu M; Yang N; Li S; Gao M; Zhao X; Lin X
J Immunol; 2022 Aug; 209(3):456-464. PubMed ID: 35831018
[TBL] [Abstract][Full Text] [Related]
36. The Ca2+-dependent phosphatase calcineurin controls the formation of the Carma1-Bcl10-Malt1 complex during T cell receptor-induced NF-kappaB activation.
Palkowitsch L; Marienfeld U; Brunner C; Eitelhuber A; Krappmann D; Marienfeld RB
J Biol Chem; 2011 Mar; 286(9):7522-34. PubMed ID: 21199863
[TBL] [Abstract][Full Text] [Related]
37. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
Front Immunol; 2018; 9():1136. PubMed ID: 29881386
[TBL] [Abstract][Full Text] [Related]
38. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.
Jiang C; Zhu Y; Zhou Z; Gumin J; Bengtsson L; Wu W; Songyang Z; Lang FF; Lin X
Oncogene; 2017 May; 36(20):2813-2823. PubMed ID: 27991920
[TBL] [Abstract][Full Text] [Related]
39. Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling.
Juilland M; Thome M
Front Immunol; 2018; 9():1927. PubMed ID: 30214442
[TBL] [Abstract][Full Text] [Related]
40. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer.
Crone SG; Jacobsen A; Federspiel B; Bardram L; Krogh A; Lund AH; Friis-Hansen L
Mol Cancer; 2012 Sep; 11():71. PubMed ID: 22992343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
